Amends the Controlled Substances Act (CSA) to add pseudoephedrine and ephedrine as schedule V substances.
Requires a distributor or pharmacy that sells such a pseudoephedrine substance to ensure that:
(1) it is dispensed or sold at retail only by a practitioner, pharmacist, or individual under the pharmacist's supervision as permitted by the state;
(2) any person purchasing, receiving, or otherwise acquiring it, prior to taking possession, provides an approved federal or state-issued photo identification (or alternative form of identification authorized by the Attorney General) and signs or makes an entry in a written or electronic log documenting the transaction date, the name of the person, and the name and amount of the substance acquired; and
(3) no person acquires more than 7.5 grams of such substance within any 30-day period.
Authorizes the Attorney General to exempt a product:
(1) upon determining that it cannot be used in the illegal manufacture of methamphetamine or any other controlled dangerous substance; or
(2) upon the manufacturer's application if the Attorney General determines that it has been formulated in such a way as to effectively prevent the conversion of the active ingredient into methamphetamine.
Allows the Attorney General to authorize the sale of such substance by persons other than a practitioner at a location other than a pharmacy if:
(1) the Attorney General determines that the retail facility is located within a commercial service airport and sells the substance packaged in liquid and liquid filled gelcaps only, with each single sales package containing not more than 360 mg.
per person in a 24-hour period;
(2) the Attorney General has issued an alternate place of sale license to the retail location and has issued an alternate dispenser license to the person authorized to make the sale;
(3) the person dispensing the substance follows procedures set forth in this Act; and
(4) the authorized person dispensing the substance provides notification of the intention to dispense such substance pursuant to a special exception to each state and local law enforcement authority with jurisdiction to investigate crimes involving controlled substances at such location.
Makes the limit inapplicable to any such substance dispensed under a valid prescription.
Sets forth requirements regarding rules for the logs, warnings of the potential consequences of false statements or misrepresentations, and alternate forms of identification to be used electronically.
Provides immunity from liability for a retailer who in good faith releases information maintained for purposes of compliance with this Act to a law enforcement or regulatory authority, unless the release constitutes gross negligence or intentional, wanton, or willful misconduct.
Permits the Attorney General to register an applicant to dispense such a substance at a location other than a pharmacy, and to register an applicant other than a practitioner to dispense such a substance at such a location, upon determining it would be consistent with the public interest.
Prohibits the Attorney General from registering an applicant who does not have a valid state license.
Requires persons registered with the Drug Enforcement Administration (DEA) to manufacture or distribute controlled substances to maintain adequate security and provide effective controls and procedures to guard against theft and diversion, but provides that such persons shall not otherwise be required to meet the storage, reporting, recordkeeping, or physical security control requirements for pseudoephedrine substances.
Provides that this Act shall not be contrued to prohibit states and their political subdivisions from:
(1) adopting and enforcing penalties that are different from those applicable under CSA; and
(2) permitting the sale of specified pediatric pseudoephedrine products.